Cargando…

Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors

Metastatic melanoma (MM) is a fatal disease with a rapid systemic dissemination. This study was conducted to investigate the metastatic behavior, timing, patterns, survival, and influencing factors in MM. 214 patients with MM were evaluated retrospectively. Distant metastases (82%) were the most fre...

Descripción completa

Detalles Bibliográficos
Autor principal: Tas, Faruk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391929/
https://www.ncbi.nlm.nih.gov/pubmed/22792102
http://dx.doi.org/10.1155/2012/647684
_version_ 1782237577599778816
author Tas, Faruk
author_facet Tas, Faruk
author_sort Tas, Faruk
collection PubMed
description Metastatic melanoma (MM) is a fatal disease with a rapid systemic dissemination. This study was conducted to investigate the metastatic behavior, timing, patterns, survival, and influencing factors in MM. 214 patients with MM were evaluated retrospectively. Distant metastases (82%) were the most frequent for patients initially metastatic. The median and 1-year survival rates of initially MM patients were 10 months and 41%, respectively. The median time to metastasis for patients with localized disease was 28 months. The timing of appearance of metastases varied minimally; however, times to metastases for distant organs varied greatly. For the first metastatic pathway, more than half of the primary metastases were M1A (57%). These findings were in contrast to the results compared with those with metastatic in diagnosis (P < 0.001). The median and 1-year survival rates of all patients were 12 months and 49%, respectively. Outcome was higher in M1A than visceral metastases (P < 0.001). In conclusion, the fact that over half of all recurrences/metastases occurred within 3 years urges us to concentrate follow-up in the early time periods following diagnosis. Because the clinical behavior of MM is variable, the factors for survival consisting of site and number of metastases should be emphasized.
format Online
Article
Text
id pubmed-3391929
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33919292012-07-12 Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors Tas, Faruk J Oncol Clinical Study Metastatic melanoma (MM) is a fatal disease with a rapid systemic dissemination. This study was conducted to investigate the metastatic behavior, timing, patterns, survival, and influencing factors in MM. 214 patients with MM were evaluated retrospectively. Distant metastases (82%) were the most frequent for patients initially metastatic. The median and 1-year survival rates of initially MM patients were 10 months and 41%, respectively. The median time to metastasis for patients with localized disease was 28 months. The timing of appearance of metastases varied minimally; however, times to metastases for distant organs varied greatly. For the first metastatic pathway, more than half of the primary metastases were M1A (57%). These findings were in contrast to the results compared with those with metastatic in diagnosis (P < 0.001). The median and 1-year survival rates of all patients were 12 months and 49%, respectively. Outcome was higher in M1A than visceral metastases (P < 0.001). In conclusion, the fact that over half of all recurrences/metastases occurred within 3 years urges us to concentrate follow-up in the early time periods following diagnosis. Because the clinical behavior of MM is variable, the factors for survival consisting of site and number of metastases should be emphasized. Hindawi Publishing Corporation 2012 2012-06-27 /pmc/articles/PMC3391929/ /pubmed/22792102 http://dx.doi.org/10.1155/2012/647684 Text en Copyright © 2012 Faruk Tas. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Tas, Faruk
Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
title Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
title_full Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
title_fullStr Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
title_full_unstemmed Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
title_short Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
title_sort metastatic behavior in melanoma: timing, pattern, survival, and influencing factors
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391929/
https://www.ncbi.nlm.nih.gov/pubmed/22792102
http://dx.doi.org/10.1155/2012/647684
work_keys_str_mv AT tasfaruk metastaticbehaviorinmelanomatimingpatternsurvivalandinfluencingfactors